Cancer Research

Which T-Cell-Redirecting Therapy Best Treats Relapsed Myeloma?
Research & Development Which T-Cell-Redirecting Therapy Best Treats Relapsed Myeloma?

The emergence of specific toxicities like Parkinsonism in CAR T-cell therapy and dysgeusia in GPRC5D-targeted antibodies creates distinct safety considerations for patients with early relapsed disease. As the oncology field moves toward more sophisticated immunotherapies, the treatment landscape

City of Hope and Adagene Launch Trial for Colorectal Cancer
Research & Development City of Hope and Adagene Launch Trial for Colorectal Cancer

Advancing Immunotherapy in the Global Oncology Landscape The current trajectory of global oncology research is defined by a rigorous departure from generalist treatments toward sophisticated, molecularly targeted therapies that prioritize long-term patient survival over temporary remission. In

Nigerian Breast Cancer Patients Ready for Genetic Testing
Research & Development Nigerian Breast Cancer Patients Ready for Genetic Testing

While approximately 95.7 percent of Nigerian breast cancer patients express readiness for genetic testing, the vast majority have a mean correct response rate of only 20.5 percent regarding recognized risk factors. The epidemiological landscape of Nigeria has undergone a profound transformation as

Closing the Equity Gap in Cancer Care Through Precision Medicine
Tech & Innovation Closing the Equity Gap in Cancer Care Through Precision Medicine

Legislative progress in 25 states has mandated biomarker testing coverage, yet many patients still face prohibitive cost-sharing requirements and frequent insurance denials for innovative modalities. The promise of precision medicine—the tailoring of medical treatment to the individual

New Study Identifies DAMA Rat Model as High-Fidelity TNBC Surrogate
Research & Development New Study Identifies DAMA Rat Model as High-Fidelity TNBC Surrogate

Recent findings demonstrate that systemic methotrexate treatment exerts selective pressure on the DAMA genome, leading to significant increases in Myc and Kras mutation frequencies. This discovery marks a pivotal moment in 2026 for the oncology community, which has long struggled to find

Can Selenium Nanoparticles Revolutionize Precision Medicine?
Research & Development Can Selenium Nanoparticles Revolutionize Precision Medicine?

High-dose selenium can act as a specific inducer of ferroptosis in lung cancer cells, triggering a regulated, iron-dependent cell death that suppresses tumor growth. This discovery highlights the paradoxical nature of a trace element that is simultaneously indispensable and potentially lethal. For

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later